Psychedelics for substance use disorders: are women being addressed? A scoping review
International Journal of Drug Policy September 2, 2025 Alexandra Wojdyslawski Nigri, Ilana Falcão de Arruda, Catarina Maia et al. 3 citations
A scoping review of 75 studies on psychedelics for substance use disorders found that most did not adequately account for sex or gender. Only 18 studies had sex-balanced samples, 46 underrepresented females, 9 included no females, and 5 did not report sex. Thirteen studies considered sex in their design, 11 conducted sex-based analyses of substance use outcomes, and only 5 acknowledged sex underrepresentation as a limitation. None addressed sex or gender in the discussion. The authors conclude that, given the recognized role of sex and gender in substance use disorder treatment, such explorations should be encouraged.